Limonene suppresses lipopolysaccharide-induced production of nitric oxide, prostaglandin E2, and pro-inflammatory cytokines in RAW 264.7 macrophages

Journal of Oleo Science

Volumn 59, Issue 8, 2010, Pages 415-421

  Yoon, Weon Jong ^a   Lee, Nam Ho ^b   Hyun, Chang Gu ^a,b  

^a Jeju Biodiversity Research Institute   (South Korea)

^b Jeju National University   (South Korea)

Author keywords

Cytokine; D limonene; Inflammation; Inos; Pge2

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; AUTACOID; CYCLOHEXENE DERIVATIVE; CYCLOOXYGENASE 2; CYTOKINE; LIMONENE; LIPOPOLYSACCHARIDE; NITRIC OXIDE; PROSTAGLANDIN E2; TERPENE;

ANIMAL; ARTICLE; CELL LINE; CELL SURVIVAL; DOWN REGULATION; DRUG EFFECT; DRUG SCREENING; MACROPHAGE; METABOLISM; MOUSE;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTICARCINOGENIC AGENTS; CELL LINE; CELL SURVIVAL; CYCLOHEXENES; CYCLOOXYGENASE 2; CYTOKINES; DINOPROSTONE; DOWN-REGULATION; DRUG EVALUATION, PRECLINICAL; INFLAMMATION MEDIATORS; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; NITRIC OXIDE; TERPENES;

EID: 77954379641     PISSN: 13458957     EISSN: 13473352     Source Type: Journal    
DOI: 10.5650/jos.59.415     Document Type: Article

References (24)

1. Sun, J. D-Limonene: Safety and clinical applications. Altern. Med. Rev. 12, 259-264 (2007).
2. Zhao, Y.; Jia, L.; Mao, X.; Xu, H.; Wang, B.; Liu, Y. siRNA-targeted COL8A1 inhibits proliferation, reduces invasion and enhances sensitivity to D-limonence treatment in hepatocarcinoma cells. IUBMB Life 61, 74-79 (2009).
3. Crowell, P. L.; Lin, S.; Vedejs, E.; Gould, M.N. Identification of metabolites of the antitumor agent D-limonene capable of inhibiting protein isoprenylation and cell growth. Cancer Chemother. Pharmacol. 31, 205-212 (1992).
4. Vigushin, D. M.; Poon, G. K.; Boddy, A.; English, J.; Halbert, G.W.; Pagonis, C.; Jarman M.; Coombes, R.C. Phase I and pharmacokinetic study of D-limonene in patients with advanced cancer. Cancer Research Campaign Phase I/II Clinical Trials Committee. Cancer Chemother. Pharmacol. 42, 111-117 (1998).
5. Dietrich, D. R.; Swenberg, J. A. (1991) The presence of alpha 2u-globulin is necessary for D-limonene promotion of male rat kidney tumors. Cancer Res. 51, 3512-3521 (1991).
6. Crowell, P. L. Prevention and therapy of cancer by dietary monoterpenes. J. Nutr. 129, 775-778 (1999).
7. Uedo, N.; Tatsuta, M.; Iishi, H.; Baba, M.; Sakai, N.; Yano, H.; Otani, T. Inhibition by D-limonene of gastric carcinogenesis induced by N-methyl-N'-nitro-N-nitrosoguanidine in Wistar rats. Cancer Lett. 137, 131-136 (1999).
8. Gordon, S. Alternative activation of macrophages. Nat. Rev. Immunol. 3, 23-35 (2003).
9. Mosser, D. M.; Edwards, J. P. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 8, 958-969 (2008).
10. Uchida, K. A lipiD-derived endogenous inducer of COX-2: A bridge between inflammation and oxidative stress. Mol. Cells 25, 347-351 (2008).
11. Kim, D. H.; Shin, E. K.; Kim, Y. H.; Lee, B. W.; Jun, J. G.; Park, J. H.; Kim, J. K. Suppression of inflammatory responses by celastrol, a quinone methide triterpenoid isolated from Celastrus regelii. Eur. J.Clin. Invest. 39, 819-827 (2009).
12. Kim, S. S.; Baik, J. S.; Oh, T. H.; Yoon, W. J.; Lee, N. H.; Hyun, C. G. Biological activities of Korean Citrus obovoidea and Citrus natsudaidai essential oils against acne-inducing bacteria. Biosci. Biotechnol. Biochem. 72, 2507-2513 (2008).
13. Yang, E. J.; Kim, S. S.; Oh, T. H.; Baik, J. S.; Lee, N. H.; Hyun, C. G. Essential oil of citrus fruit waste attenuates LPS-induced nitric oxide production and inhibits the growth of skin pathogens. Int. J. Agri. Biol. 11, 791-794 (2009).
14. Kinne, R. W.; Bräuer, R.; Stuhlmüller, B.; Palombo-Kinne, E.; Burmester, G. R. Macrophages in rheumatoid arthritis. Arthritis Res. 2, 189-202 (2000).
15. Duffield, J. S. The inflammatory macrophage: A story of Jekyll and Hyde. Clin. Sci. 104, 27-38 (2003).
16. Park, J. S.; Lee, E. J.; Lee, J. C.; Kim, W. K.; Kim, H. S. Anti-inflammatory effects of short chain fatty acids in IFN-gamma-stimulated RAW 264.7 murine macrophage cells: involvement of NF-kappaB and ERK signaling pathways. Int. Immunopharmacol. 7, 70-77 (2007).
17. Nam, N. H. Naturally occurring NF-kappaB inhibitors. Mini Rev. Med. Chem. 6, 945-951 (2006).
18. Tsatsanis, C.; Androulidaki, A.; Venihaki, M.; Margioris, A.N. Signalling networks regulating cyclooxygenase-2. Int. J. Biochem. Cell Biol. 38, 1654-1661 (2006).
19. González-Gallego, J.; Sánchez-Campos, S.; Tuñón, M. J. Anti-inflammatory properties of dietary flavonoids. Nutr. Hosp. 22, 287-293 (2007).
20. Murakami, A.; Ohigashi, H. Targeting NOX, INOS and COX-2 in inflammatory cells: chemoprevention using food phytochemicals. Int. J. Cancer 121, 2357-2363 (2007).
21. Kurylowicz, A.; Nauman, J. The role of nuclear factor-kappaB in the development of autoimmune diseases: A link between genes and environment. Acta Biochim. Pol. 55, 629-647 (2008).
22. Kataoka, T. Chemical biology of inflammatory cytokine signaling. J. Antibiot. 62, 655-667 (2009).
23. Patel, S.; Santani, D. Role of NF-kappaB in the pathogenesis of diabetes and its associated complications. Pharmacol. Rep. 61, 595-603 (2009).
24. Wong, E. T.; Tergaonkar, V. Roles of NF-kappaB in health and disease: mechanisms and therapeutic potential. Clin, Sci. 116, 451-465 (2009).